Name the vaccination against tuberculosis. What type of vaccination is it? Bacillus Calmette-Guérin (BCG) is a live attenuated strain of Mycobacterium bovis. It was discovered in 1921, but has not been widely used in the United States, with the exception of a very small number of at-risk infants who cannot receive chemoprophylaxis. In third-world countries, the BCG vaccine is widely used. This vaccination is contraindicated in immunosuppressed individuals who are at risk of disseminated M. bovis infection. Intravesical BCG is also commonly used as treatment for bladder cancer, and there have been reports of cutaneous tuberculous lesions following this therapy. Hillyer S, Gulmi FA: Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male, Can J Urol 16(5):4866–4869, 2009. Gontero P, Bohle A, Malmstrom PU, et al: The role of Bacillus Calmette-Guérin in the treatment of non–muscle-invasive bladder cancer, Eur Urol 57:410–429, 2010. [Epub ahead of print.] Ng YH, Bramwell SP, Palmer TJ, Woo WK: Cutaneous mycobacterial infection postintravesical BCG installation, Surgeon 4(1):57–58, 2006. |
© 2024 Skin Disease & Care | All Rights Reserved.